Violich Capital Management Inc. Makes New $499,000 Investment in Astera Labs, Inc. $ALAB

Violich Capital Management Inc. acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 3,000 shares of the company’s stock, valued at approximately $499,000.

Several other large investors have also recently bought and sold shares of the company. Nordea Investment Management AB acquired a new position in shares of Astera Labs in the 4th quarter valued at $2,028,000. Geneva Partners LLC acquired a new position in shares of Astera Labs in the 3rd quarter valued at $1,876,000. Numerai GP LLC lifted its stake in shares of Astera Labs by 153.1% in the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the period. Handelsbanken Fonder AB lifted its stake in shares of Astera Labs by 289.5% in the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares during the period. Finally, Paragon Advisors LLC acquired a new position in shares of Astera Labs in the 3rd quarter valued at $1,829,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Stock Down 8.5%

ALAB opened at $195.65 on Friday. Astera Labs, Inc. has a 12 month low of $69.26 and a 12 month high of $262.90. The company has a fifty day simple moving average of $143.77 and a 200 day simple moving average of $153.99. The stock has a market cap of $33.51 billion, a P/E ratio of 132.20, a P/E/G ratio of 4.21 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 19.36%. The business had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the prior year, the company earned $0.33 EPS. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts expect that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Jitendra Mohan sold 10,188 shares of the company’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $175.45, for a total value of $1,787,484.60. Following the completion of the sale, the chief executive officer owned 4,069,134 shares in the company, valued at $713,929,560.30. This represents a 0.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares of the company’s stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,064,888 shares of company stock worth $150,764,723 in the last 90 days. Corporate insiders own 12.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ALAB shares. Stifel Nicolaus increased their price target on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday. JPMorgan Chase & Co. increased their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday. Rothschild & Co Redburn started coverage on Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. Weiss Ratings raised Astera Labs from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Finally, Roth Mkm reissued a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research note on Wednesday. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $229.65.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.